Predicting own cardiovascular risk hard for patients | Study: Healthy diet is beneficial for women with history of gestational diabetes | Fresh fruit shown to lower rates of cardiovascular disease
April 21, 2016
PCNA SmartBrief
News about cardiovascular disease prevention and management
Heart Health News
Predicting own cardiovascular risk hard for patients
Overestimation of personal cardiovascular risk may be common, according to a study presented at a meeting of the American College of Cardiology. Only 1 in 4 of 2,856 adults correctly assessed their risk of developing cardiovascular disease within 10 percentage points, with women and younger adults tending to overestimate their risk while men and older adults underestimated it.
Endocrinology Advisor (4/15) 
LinkedIn Twitter Facebook Google+ Email
Study: Healthy diet is beneficial for women with history of gestational diabetes
Researchers found that women with a history of gestational diabetes were almost 25% less likely to develop high blood pressure if they ate a healthy diet, compared with those with the least healthy diets. The findings in the journal Hypertension were based on nearly 4,000 women in the Nurses' Health Study II.
Reuters (4/18) 
LinkedIn Twitter Facebook Google+ Email
Fresh fruit shown to lower rates of cardiovascular disease
Even a small amount of fresh fruit in a person's diet can lower the risk of cardiovascular death by some 33%, according to a recent study by the University of Oxford and the Chinese Academy of Medical Sciences. It is the first such study to involve large numbers of Chinese citizens.
FoodNavigator (4/19) 
LinkedIn Twitter Facebook Google+ Email
Other News
Emerging Trends
Study examines warfarin safety in patients with AFib
Warfarin treatment, when well-managed, has relatively low rates of complication and all-cause mortality for patients with atrial fibrillation, according to a study in JAMA Cardiology. Based on data from 40,000 Swedish patients, the annual rate of intracranial bleeding was 0.44% with warfarin, while the rate of major bleeding was about 3% among those who took both warfarin and aspirin.
HealthDay News (4/20) 
LinkedIn Twitter Facebook Google+ Email
Cardiovascular mortality risk lower with metformin than other drugs
An analysis in the Annals of Internal Medicine found that the use of the type 2 diabetes medication metformin was associated with about 30% to 40% lower risk of dying from heart attack and stroke compared with sulfonylureas. The findings were based on 204 studies that included 1.4 million people.
HealthDay News (4/18) 
LinkedIn Twitter Facebook Google+ Email
Nursing in the News
Relationships, communication are key to developing nurse leaders
Nurse educators shape the development of nurse leaders by shaping students' understanding of leadership and fostering a respectful, communicative environment, writes lawyer and nurse Nancy Brent. "Experiencing a nurturing relationship with faculty members allows nurses in other roles to reciprocate that experience to others with whom they come in contact and avoid potential legal troubles," Brent writes. (4/18) 
LinkedIn Twitter Facebook Google+ Email
PCNA Update
CE Spotlight: Communicating Risk
New in PCNA's on-demand library this month is a complimentary course titled Beyond Scare Tactics: Effective Risk Communication Strategies. In this course, you will hear insights on which risk assessment tools work best with different patients and learn about evidence-based approaches for communicating risk. This course is worth 0.92 continuing education credits. Take this course and see the other offerings in PCNA's On-Demand Library.
LinkedIn Twitter Facebook Google+ Email
Learn more about PCNA:
Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
Tomorrow is the only day in the year that appeals to a lazy man.
Jimmy Lyons,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Rebecca Adelson
P: 202.618.5665
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information